LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s. 

Within healthcare, artificial intelligence and quality improvement have some things in common. 

In a new report, the New York Times details multiple incidents of the insurance giant using legal threats to silence social media users and news outlets, citing the murder of Brian Thompson and the threat of rising violence as the basis for its claims. 

The Consumer Financial Protection Bureau joined trade lobby groups in asking a federal court to vacate the rule, which would have forbidden creditors from considering medical debt in lending decisions.

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.

“Leaders in radiology must prioritize embedding a culture of feedback within their institutions, recognizing its crucial role in continuous improvement," experts charge.